Home > Riviste > Minerva Biotecnologica > Fascicoli precedenti > Minerva Biotecnologica 2009 June;21(2) > Minerva Biotecnologica 2009 June;21(2):135-46

ULTIMO FASCICOLO
 

ARTICLE TOOLS

Estratti

MINERVA BIOTECNOLOGICA

Rivista di Biologia Molecolare e Biotecnologie


Indexed/Abstracted in: EMBASE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,246


eTOC

 

  MOLECULAR IMAGING AND BIOTECHNOLOGY


Minerva Biotecnologica 2009 June;21(2):135-46

Copyright © 2009 EDIZIONI MINERVA MEDICA

lingua: Inglese

Methods and techniques for preclinical in vivo evaluation of radiosensitivity and radioresponsivity

Martelli C. 1,2, Luraschi R. 3, Ottobrini L. 1,2, Lecchi M. 1,2,3, Libani I. V. 1,2, Lucignani G. 1,2,3

1 Department of Biomedical Sciences and Technologies Section of Radiological Sciences University of Milan, Milan, Italy
2 Centre of Molecular and Cellular Imaging – IMAGO University of Milan, Milan, Italy
3 Unit of Nuclear Medicine, San Paolo Hospital, Milan, Italy.


FULL TEXT  


Over the years, radiotherapy (RT) has considerably broadened the possibility for treating tumors and led to an overall improvement in the quality of life of cancer patients. Cancer-cell radiosensitivity and radioresponsivity, being related to patient-specific tumor features and conditions, such as proliferation rate, metabolism, percentage of apoptosis, new vessel formation and level of hypoxia, influence the efficacy of RT treatment. Radiosensitivity and radioresponsivity can now be studied in the clinical setting using in vivo molecular imaging techniques, such as positron emission tomography, single photon emission tomography and magnetic resonance imaging. Furthermore, the availability of many new radiotracers and imaging probes is improving the approach to the exploration of tumor response to RT. However, to be successful in clinical, in vivo imaging investigations require an in-depth understanding of the molecular basis of tumor response to RT. Small-animal models of neoplasia are now an essential tool for the preclinical evaluation of novel anti-neoplastic therapies, also at molecular level. However, the accuracy of RT techniques for small animal needs to be improved. Indeed, human conformal RT devices are less accurate when used in small-animal irradiation, which involves relatively small radiation fields and demands more precise beam localisation than is typical of clinical irradiators. The aim of this paper is to review current preclinical protocols and small-animal models for the in vivo study of radiosensitivity and radioresponsivity. More-over, the new solutions for dedicated small-animal conformal RT devices are also analyzed.

inizio pagina

Publication History

Per citare questo articolo

Corresponding author e-mail